Designed for use with the binx health io Instrument, this fully automated, rapid, qualitative test is intended for use in point-of-care or clinical laboratory settings for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae DNA by polymerase chain reaction. The system delivers central lab-quality results in around 30 minutes for both male and female patients. The rapid turnaround time supports test-and-treat patient care at the time of visit for those who need it and curbs unnecessary empiric treatment for those who don’t. Additionally, the binx io CT/NG Assay provides clinics with the ability to make a profit performing the testing in-house while providing superior patient care.